Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions

Sudarshana Purkayastha, Jason Ford, Baishali Kanjilal, Souleymane Diallo, Joseph Del Rosario Inigo, Lorenz Neuwirth, Abdeslem El Idrissi, Zaghloul Ahmed, Andrzej Wieraszko, Efrain C. Azmitia, Probal Banerjee

Research output: Contribution to journalArticle

Abstract

Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the post-synaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT 1A-R), phospholipase Cβ, and Ca 2+/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT 1A-R-mediated. Intriguingly, the NMDA receptor (NMDA-R) antagonist (±)2-amino-5- phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT 1A-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT 1A-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R 2B (NR2B) subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the post-synaptic membrane and an increase in fEPSP. Co-immunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT 1A-R, possibly in the membrane rafts of the post-synaptic density (PSD), because pretreatment with methyl-β- cyclodextrin (MCD), an agent that disrupts rafts, inhibited both co-immunoprecipitation as well as fEPSP. In summary, Clz functions in the PFC by orchestrating a synergism among 5-HT 1A-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III. How clozapine worksNerve signals in the analytical center of the brain prefrontal cortex (PFC) are impaired in Schizophrenia but how the therapeutic agent clozapine normalizes these signals is unknown. This study analyzes nerve signals and molecular interactions in the PFC to explain how clozapine works. Our findings unify multiple prior hypotheses into one mechanistic model for the action of clozapine.

Original languageEnglish (US)
Pages (from-to)396-407
Number of pages12
JournalJournal of Neurochemistry
Volume120
Issue number3
DOIs
StatePublished - Feb 2012

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinases
Receptor, Serotonin, 5-HT1A
Clozapine
Prefrontal Cortex
N-Methyl-D-Aspartate Receptors
Calcium-Calmodulin-Dependent Protein Kinase Type 2
Serotonin
Synaptic Potentials
Excitatory Postsynaptic Potentials
N-Methylaspartate
Immunoprecipitation
Schizophrenia
Population
2-Amino-5-phosphonovalerate
Isoxazoles
Membranes
Post-Synaptic Density
Synaptic Membranes
AMPA Receptors
Molecular interactions

Keywords

  • 5-HT1A receptor
  • clozapine
  • prefrontal cortex
  • schizophrenia
  • signal transduction

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. / Purkayastha, Sudarshana; Ford, Jason; Kanjilal, Baishali; Diallo, Souleymane; Del Rosario Inigo, Joseph; Neuwirth, Lorenz; El Idrissi, Abdeslem; Ahmed, Zaghloul; Wieraszko, Andrzej; Azmitia, Efrain C.; Banerjee, Probal.

In: Journal of Neurochemistry, Vol. 120, No. 3, 02.2012, p. 396-407.

Research output: Contribution to journalArticle

Purkayastha, S, Ford, J, Kanjilal, B, Diallo, S, Del Rosario Inigo, J, Neuwirth, L, El Idrissi, A, Ahmed, Z, Wieraszko, A, Azmitia, EC & Banerjee, P 2012, 'Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions', Journal of Neurochemistry, vol. 120, no. 3, pp. 396-407. https://doi.org/10.1111/j.1471-4159.2011.07565.x
Purkayastha, Sudarshana ; Ford, Jason ; Kanjilal, Baishali ; Diallo, Souleymane ; Del Rosario Inigo, Joseph ; Neuwirth, Lorenz ; El Idrissi, Abdeslem ; Ahmed, Zaghloul ; Wieraszko, Andrzej ; Azmitia, Efrain C. ; Banerjee, Probal. / Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. In: Journal of Neurochemistry. 2012 ; Vol. 120, No. 3. pp. 396-407.
@article{eda68662480043fc9fcf6655e349f87b,
title = "Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions",
abstract = "Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the post-synaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT 1A-R), phospholipase Cβ, and Ca 2+/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT 1A-R-mediated. Intriguingly, the NMDA receptor (NMDA-R) antagonist (±)2-amino-5- phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT 1A-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT 1A-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R 2B (NR2B) subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the post-synaptic membrane and an increase in fEPSP. Co-immunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT 1A-R, possibly in the membrane rafts of the post-synaptic density (PSD), because pretreatment with methyl-β- cyclodextrin (MCD), an agent that disrupts rafts, inhibited both co-immunoprecipitation as well as fEPSP. In summary, Clz functions in the PFC by orchestrating a synergism among 5-HT 1A-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III. How clozapine worksNerve signals in the analytical center of the brain prefrontal cortex (PFC) are impaired in Schizophrenia but how the therapeutic agent clozapine normalizes these signals is unknown. This study analyzes nerve signals and molecular interactions in the PFC to explain how clozapine works. Our findings unify multiple prior hypotheses into one mechanistic model for the action of clozapine.",
keywords = "5-HT1A receptor, clozapine, prefrontal cortex, schizophrenia, signal transduction",
author = "Sudarshana Purkayastha and Jason Ford and Baishali Kanjilal and Souleymane Diallo and {Del Rosario Inigo}, Joseph and Lorenz Neuwirth and {El Idrissi}, Abdeslem and Zaghloul Ahmed and Andrzej Wieraszko and Azmitia, {Efrain C.} and Probal Banerjee",
year = "2012",
month = "2",
doi = "10.1111/j.1471-4159.2011.07565.x",
language = "English (US)",
volume = "120",
pages = "396--407",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions

AU - Purkayastha, Sudarshana

AU - Ford, Jason

AU - Kanjilal, Baishali

AU - Diallo, Souleymane

AU - Del Rosario Inigo, Joseph

AU - Neuwirth, Lorenz

AU - El Idrissi, Abdeslem

AU - Ahmed, Zaghloul

AU - Wieraszko, Andrzej

AU - Azmitia, Efrain C.

AU - Banerjee, Probal

PY - 2012/2

Y1 - 2012/2

N2 - Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the post-synaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT 1A-R), phospholipase Cβ, and Ca 2+/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT 1A-R-mediated. Intriguingly, the NMDA receptor (NMDA-R) antagonist (±)2-amino-5- phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT 1A-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT 1A-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R 2B (NR2B) subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the post-synaptic membrane and an increase in fEPSP. Co-immunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT 1A-R, possibly in the membrane rafts of the post-synaptic density (PSD), because pretreatment with methyl-β- cyclodextrin (MCD), an agent that disrupts rafts, inhibited both co-immunoprecipitation as well as fEPSP. In summary, Clz functions in the PFC by orchestrating a synergism among 5-HT 1A-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III. How clozapine worksNerve signals in the analytical center of the brain prefrontal cortex (PFC) are impaired in Schizophrenia but how the therapeutic agent clozapine normalizes these signals is unknown. This study analyzes nerve signals and molecular interactions in the PFC to explain how clozapine works. Our findings unify multiple prior hypotheses into one mechanistic model for the action of clozapine.

AB - Aberrant dopamine release in the prefrontal cortex (PFC) is believed to underlie schizophrenia, but the mechanistic pathway through which a widely used antipsychotic, clozapine (Clz), evokes neurotransmitter-releasing electrical stimulation is unclear. We analyzed Clz-evoked regulation of neuronal activity in the PFC by stimulating axons in layers IV and V and recording the electrical effect in the post-synaptic pyramidal cells of layers II and III. We observed a Clz-evoked increase in population spike (PS), which was mediated by serotonin 1A receptor (5-HT 1A-R), phospholipase Cβ, and Ca 2+/calmodulin-dependent protein kinase II (CaMKII). Immunoblotting demonstrated that the Clz-activation of CaMKII was 5-HT 1A-R-mediated. Intriguingly, the NMDA receptor (NMDA-R) antagonist (±)2-amino-5- phosphonovaleric acid (APV) eliminated the Clz-mediated increase in PS, suggesting that the 5-HT 1A-R, NMDA-R and CaMKII form a synergistic triad, which boosts excitatory post-synaptic potential (EPSP), thereby enhancing PS. In corroboration, Clz as well as NMDA augmented field EPSP (fEPSP), and WAY100635 (a 5-HT 1A-R antagonist), APV, and a CaMKII inhibitor eliminated this increase. As previously shown, CaMKII binds to the NMDA-R 2B (NR2B) subunit to become constitutively active, thereby inducing α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor recruitment to the post-synaptic membrane and an increase in fEPSP. Co-immunoprecipitation demonstrated that Clz potentiates interactions among CaMKII, NR2B, and 5-HT 1A-R, possibly in the membrane rafts of the post-synaptic density (PSD), because pretreatment with methyl-β- cyclodextrin (MCD), an agent that disrupts rafts, inhibited both co-immunoprecipitation as well as fEPSP. In summary, Clz functions in the PFC by orchestrating a synergism among 5-HT 1A-R, CaMKII, and NMDA-R, which augments excitability in the PFC neurons of layers II/III. How clozapine worksNerve signals in the analytical center of the brain prefrontal cortex (PFC) are impaired in Schizophrenia but how the therapeutic agent clozapine normalizes these signals is unknown. This study analyzes nerve signals and molecular interactions in the PFC to explain how clozapine works. Our findings unify multiple prior hypotheses into one mechanistic model for the action of clozapine.

KW - 5-HT1A receptor

KW - clozapine

KW - prefrontal cortex

KW - schizophrenia

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84855716018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855716018&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2011.07565.x

DO - 10.1111/j.1471-4159.2011.07565.x

M3 - Article

C2 - 22044428

AN - SCOPUS:84855716018

VL - 120

SP - 396

EP - 407

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -